04:52 AM EDT, 05/08/2025 (MT Newswires) -- Takeda Pharmaceutical ( TAK ) reported fiscal Q4 core earnings Thursday of 49 Japanese yen ($0.34) per share, down from 72 yen a year earlier.

Four analysts polled by FactSet expected 55.38 yen.

Revenue for the quarter ended March 31 was 1.053 trillion yen, up from 1.051 trillion yen a year earlier.

Analysts surveyed by FactSet expected 1.073 trillion yen.

The company expects core EPS for its next fiscal year to be 485 yen. Analysts surveyed by FactSet expect 508.33 yen.

The company expects full-year revenue of 4.530 trillion yen. Analysts polled by FactSet expects 4.602 trillion yen.

Takeda shares were down 3% in recent premarket activity.